Brain Cancer @ Leeds

Dr Lucy Stead – Group Leader

Contact Information
Grants Awarded
PhD Studentship Opportunites

Contact Information

Dr Lucy Stead
University Academic Fellow
Leeds Institute of Cancer and Pathology
Wellcome Trust Brenner Building
St James’s University Hospital
LS9 7TF, Leeds
United Kingdom

tel: +44 (0) 113 3438410
twitter: @LucyFStead


I am interested in investigating intratumour heterogeneity in GBM; specifically I wish to test whether treatment-resistant subclones emerge in recurrent tumours, and characterise them in clinically relevant ways in multiple patients. I am a trained computational biologist with expertise in next-generation sequencing data analysis.


Grants Awarded

Selected Publications

The GLASS Consortium members (2018)
Glioma Through the Looking GLASS: Molecular Evolution of Diffuse Gliomas and the Glioma Longitudinal AnalySiS Consortium
[Accepted Manuscript]

Samson A, Scott K, Taggart D†, West E, Wilson E, Nuovo G, Thomson S, Corns R, Mathew R, Fuller M, Kottke T, Thompson J, Ilett E, Cockle J, Van Hille P, Sivakumar G, Polson E, Turnbull S, Appleton E, Migneco G, Rose A, Coffey M, Beirne D, Collinson F, Ralph C, Anthoney A, Twelves C, Furness A, Quezada S, Wurdak H, Errington-Mais F, Pandha H, Harrington K, Selby P, Vile R, Griffin S, Stead, L.F, Short S, Melcher A (2018)
Intravenous Delivery of Oncolytic Reovirus to Brain Tumor Patients Immunologically Primes for Subsequent Checkpoint Blockade
Science Translational Medicine. Jan;10(422). pii: eaam7577

Droop, A., Bruns, A.F., Tanner, G., Rippaus, N., Morton, R., Harrison, S., King, H., Ashton, K., Syed, K., Jenkinson, M.D., Brodbelt, A., Chakrabarty, A.,Ismail, A., Short, S. and Stead, L.F (2018)
How to Analyse The Spatiotemporal Tumour Samples Needed To Investigate Cancer Evolution: A Case Study using Paired Primary and Recurrent Glioblastoma
International Journal of Cancer. Apr;142(8):1620-1626

Hurst, C.D, Alder, O., Platt, F.M., Droop, A., Stead, L.F, Burns, J.E., Burghel, G.J., Jain, S., Klimczak, L.J., Lindsay, H., Roulson, J.A., Taylor, C.F., Thygesen, H., Cameron, A.J., Ridley, A.J., Mott, H.R., Gordenin, D.A., Knowles, M.A. (2017)
Genomic Subtypes of Non-Invasive Bladder Cancer with Distinct Metabolic Profile, Clinical Outcome and Female Gender Bias in KDM6A Mutation Frequency
Cancer Cell. Nov;32(5):701-715.

Webster, P., Littlejohns, A., Gaunt, H., Young, R., Rode, B., Ritchie, J., Stead, L.F., Harrison, S., Droop., A, Martin, H., Tomlinson, D., Hyman, A., Appleby, H., Boxall, S., Bruns, A., Li, J., Prasad, K., Lodge, J., Burke, D. and Beech, D. (2017)
Upregulated WEE1 protects endothelial cells of colorectal cancer liver metastases.
Oncotarget. Jun;8(26):42288-42299.

King, H.O., Payne, H.L., Wright, A., Brend, T., Patel, K., Egnuni, T., Stead, L.F., Patel, A., Wurdak, H., and Short, S.C. (2017)
Rad51 is a Selective DNA Repair Target to Radiosensitise Glioma Stem Cells.
Stem Cell Reports. Jan; 8(1):125-139.

Humphries, M.P, Rajan, S.S, Droop, A., Suleman, C., Carbone, C., Nilsson, C., Honarpisheh, H., Cserni, G., Dent, J., Fulford, L., Jordan,L.B., Jones, J.L., Kanthan, R., Litwiniuk, M., Di Benedetto, A., Mottolese, M., Provenzano, E., Shousha, S., Stephens, M., Walker, R.A., Kulka, J., Ellis, I.O, Jeffery, M., Thygesen, H.H., Cappelletti, V., Daidone, M.G., Hedenfalk, I.A, Fjällskog, M., Melisi, D., Stead, L.F., Shaaban, A. and Speirs, V. (2017)
A Case Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic and Tractable Biomarkers in Male Breast Cancer.
Clin Cancer Res. May; 23(10):2575-2583

Town, J., Pais, H., Harrison, S., Stead, L.F., Bataille, C., Bonjobpol, W., Zhang, J., and Rabbitts, T.H. (2016)
Exploring the surfaceome of Ewing sarcoma identifies a new and unique therapeutic target.
PNAS. Mar; 113(13):3603-8

Conway, C., Graham, J.L., Chengot, P., Daly, C., Chalkley, R., Ross, L., Droop, A.,Rabbitts, P. and Stead, L.F. (2015)
Elucidating drivers of oral epithelial dysplasia formation and malignant transformation to cancer using RNAseq.
Oncotarget. Nov; 6 (37): 40186-40201

Wood H.M., Conway C., Daly C., Chalkley R., Berri S., Senguven B., Stead L.F., Ross L., Egan P., Chengot P., Graham J.L., Sethi N., Ong T.K., High A., MacLennan K. and Rabbitts P.(2015)
The clonal relationships between pre-cancer and cancer revealed by ultra-deep sequencing
The Journal of Pathology. Nov; 237(3):296-306

Smith, L., Baxter, E.W., Chambers, P.A., Green, C.A., Hanby, A.M., Hughes, T.A., Nash, C.E., Millican-Slater, R.A., Stead, L.F., Verghese, E.T. and Speirs, V. (2015)
Down-regulation of miR-92 in breast epithelial cells and in normal but not tumour fibroblasts contributes to breast carcinogenesis.
PLOS One. Oct; 10(10): e0139698

Samman M., Wood H.M., Conway C., Stead L.F.,  Daly C., Chalkley R., Berri S., Senguven B., Ross L., Egan P., Chengot P., Ong T.K., Pentenero M., Gandolfo S., Cassenti A., Cassoni P., Al Ajlan A., Samkari A., Barrett W., MacLennan K., High A. and Rabbitts P. (2015)
A novel genomic signature reclassifies an oral cancer subtype
International Journal of Cancer. Nov; 137(10):2364-73

Stead, L.F., Thygesen, H.,Westhead, D.R. and Rabbitts, P. (2015)
Using common variants to indicate cancer genes.
International Journal of Cancer. Jan;136(1):241-245

Stead L.F., Devery A., Conway C., Egan P., Daly C., Berri S., Wood H.M., Belvedere O., Papagiannopoulos K., Ryan A., Rabbitts P. (2013)
An Integrated Inspection of the Somatic Mutations in a Lung Squamous Cell Carcinoma using Next-Generation Sequencing.
PLOS one. Nov;8(11):e78823

Stead LF, Sutton KM, Taylor GR, Quirke P and Rabbitts, P. (2013)
Accurately identifying low-allelic fraction variants in single samples with next-generation sequencing; applications in tumour subclone resolution.
Human Mutation. Oct;34(10):1432-8

Chambers PA*, Stead LF*, Morgan JE, Carr IM, Sutton KM, Watson CM, Crowe V, Dickinson H, Roberts P, Mulatero C, Seymour M, Markham AF, Waring PM, Quirke P, Taylor GR. (2013)
Mutation Detection by Clonal Sequencing of PCR Amplicons and Grouped Read Typing is Applicable to Clinical Diagnostics.
Human Mutation. Jan;34(1):248-54

Stead L.F., Berri S., Wood H.M., Egan P., Conway C., Daly C., Papagiannopoulos K., Rabbitts P. (2012)
The transcriptional consequences of somatic amplifications, deletions, and rearrangements in a human lung squamous cell carcinoma.
Neoplasia. Nov;14(11):1075-86.

Stead L.F., Wood I.C. and Westhead D.R. (2011)
KvSNP; Accurately Predicting the Effect of Genetic Variants in Voltage-Gated Potassium Channels
Bioinformatics: Aug 15;27(16):2181-6

Abbas L, Hajihashemi S, Stead L.F., Cooper GJ, Ware TL, Munsey TS, Whitfield TT, White SJ. (2011)
Functional and developmental expression of a zebrafish Kir1.1 (ROMK) potassium channel homologue Kcnj1.
J Physiol. Mar;589(6):1489-503.

Stead L.F., Wood I.C. and Westhead D.R. (2010)
KvDB; Mining and Mapping Sequence Variants in Voltage-Gated Potassium Channels
Human Mutation: Aug;31(8):908-17.

PhD Studentship Opportunites

If you are interested in completing a PhD in Dr Stead’s group, please contact her directly. There are no funded studentships available at present but expressions of interest, or self-funded students, are always welcomed.


© Copyright Leeds 2018